New tool uses UV light to control inflammation by Office of Marketing and Communications. Media Relations
6/19/2017 New tool uses UV light to control inflammation | Cornell Chronicle
http://news.cornell.edu/stories/2016/11/new­tool­uses­uv­light­control­inflammation 1/2
June 19, 2017
Search Chronicle
 Bookmarks
Science, Tech & Medicine Arts & Humanities Business, Law & Society Campus Life Global Outreach Archive
Search Cornell
Bibudha Parasar/Provided
This fluorescence image demonstrates how light­activated chemical
probes developed by the Chang Laboratory were used to selectively
turn off inflammatory activities of immune cells that were irradiated
with light, denoted by the dotted line. Irradiated cells are shown in
red, and inflammatory molecules are shown in cyan.
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New tool uses UV light to control in.ammation
By Krishna Ramanujan
Black light does more than make
posters glow. Cornell researchers
have developed a chemical tool to
control in��ammation that is
activated by ultraviolet (UV) light.
The method will allow scientists to
study in��ammation and the
immune system, and may one day
prove e�ective as a targeted
therapy for in��ammatory diseases,
while minimizing side e�ects to
healthy tissues.
The researchers, who reported
their results in a study published in
October in the journal Chemical
Science, designed a small molecule
that is capable of controlling an
immune response when exposed to
UV light radiation.
“Currently, there aren’t a lot of tools
that are able to manipulate the
immune system in a spatio-temporal fashion,” said Pamela Chang, assistant professor of
microbiology and immunology, and the paper’s senior author. Bibudha Parasar, a graduate
student in Chang’s lab, is the paper’s �rst author.
“We are pushing the forefront of developing new technologies to control in��ammation and the
immune system, with the ultimate goal of being able to study these biological pathways and
perhaps develop therapies for in��ammatory diseases,” Chang said.
In��ammation is caused by the immune system as one of the body’s responses to eliminate
infectious pathogens and other foreign or dangerous agents. When in��ammation becomes
chronic, it can lead to a host of diseases, including asthma, multiple sclerosis, rheumatoid
arthritis, colitis and Crohn’s disease.
The researchers created a chemical probe that inhibits a reaction mediated by enzymes called
histone deacetylases (HDACs). These enzymes regulate genes that turn on when the immune
system is challenged and promote in��ammation. HDACs also have inhibitors that suppress this
in��ammatory response, and the probe speci�cally activates these inhibitors but only in the
presence of UV light. This is especially useful since HDACs are ubiquitous and have other
biological e�ects, and most drugs a�ect the entire system, leading to unintended consequences.
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“If you turned o� all the HDACs in the body, you would probably be hitting a lot of pathways that
you didn’t want to turn o�,” said Chang. “We can control when and where we turn o� the HDACs
using light. The idea is that you can actually target the tissue that has chronic in��ammation and
regulate it by selectively inhibiting HDACs in the tissue that’s a�ected.”
Photodynamic therapies are being developed and have existing infrastructure in the clinic for
the potential use of the new tool to inhibit in��ammation in patients with in��ammatory diseases,
Chang said.
The study was supported by a President’s Council of Cornell Women A�nito-Stewart Grant.
